NUR 104 PHARMACOLOGY EXAM 2 CARDIOVASCULAR DRUGS 100 QUESTIONS AND
CORRECT ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES 2026 Q&A |STUDY GUIDE|
INSTANT DOWNLOAD PDF
,Core Domains
Antihypertensive Agents
Antiarrhythmic Drugs
Anticoagulants and Antiplatelets
Diuretics in Cardiovascular Care
Cardiac Glycosides and Inotropes
Vasodilators and Nitrates
Beta-Blockers and Calcium Channel Blockers
Heart Failure Pharmacotherapy
, Lipid-Lowering Agents
Emergency Cardiovascular Medications
*
Introduction
This comprehensive pharmacology assessment evaluates critical knowledge and clinical decision-making skills
essential for safe and effective nursing practice in cardiovascular care. The exam focuses on major drug classes
used to treat hypertension, arrhythmias, heart failure, thromboembolic disorders, and coronary artery disease.
Through 100 multiple-choice and scenario-based questions, you will demonstrate mastery of mechanisms of
action, therapeutic indications, nursing monitoring parameters, adverse effects, contraindications, and patient
education requirements. The assessment emphasizes real-world application, requiring you to prioritize
interventions, recognize medication toxicity, interpret laboratory values, and make safe clinical judgments in
diverse patient scenarios. Success on this exam demonstrates readiness for clinical practice and NCLEX-RN
preparation.
***
SECTION ONE: QUESTIONS 1–100
Question 1
A patient with hypertension is prescribed lisinopril. Which nursing monitoring parameter is most critical before
administering this medication?
, A. Serum glucose level
B. Blood pressure and potassium level
C. White blood cell count
D. Urine output
🟢 B. Blood pressure and potassium level
🔴 RATIONALE: ACE inhibitors like lisinopril lower blood pressure and can cause hyperkalemia by reducing
aldosterone secretion. Monitoring BP prevents administering to hypotensive patients, and checking potassium
identifies dangerous hyperkalemia.
Question 2
Which drug class is the preferred initial therapy for a patient with heart failure and reduced ejection fraction
(HFrEF)?
A. Calcium channel blockers
B. ACE inhibitors or ARBs
C. Beta-blockers only
D. Nitrates
🟢 B. ACE inhibitors or ARBs
🔴 RATIONALE: ACE inhibitors (or ARBs if ACE inhibitors are contraindicated) are first-line therapy for
HFrEF because they reduce afterload, prevent ventricular remodeling, and decrease mortality. Beta-blockers
are added subsequently.
CORRECT ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES 2026 Q&A |STUDY GUIDE|
INSTANT DOWNLOAD PDF
,Core Domains
Antihypertensive Agents
Antiarrhythmic Drugs
Anticoagulants and Antiplatelets
Diuretics in Cardiovascular Care
Cardiac Glycosides and Inotropes
Vasodilators and Nitrates
Beta-Blockers and Calcium Channel Blockers
Heart Failure Pharmacotherapy
, Lipid-Lowering Agents
Emergency Cardiovascular Medications
*
Introduction
This comprehensive pharmacology assessment evaluates critical knowledge and clinical decision-making skills
essential for safe and effective nursing practice in cardiovascular care. The exam focuses on major drug classes
used to treat hypertension, arrhythmias, heart failure, thromboembolic disorders, and coronary artery disease.
Through 100 multiple-choice and scenario-based questions, you will demonstrate mastery of mechanisms of
action, therapeutic indications, nursing monitoring parameters, adverse effects, contraindications, and patient
education requirements. The assessment emphasizes real-world application, requiring you to prioritize
interventions, recognize medication toxicity, interpret laboratory values, and make safe clinical judgments in
diverse patient scenarios. Success on this exam demonstrates readiness for clinical practice and NCLEX-RN
preparation.
***
SECTION ONE: QUESTIONS 1–100
Question 1
A patient with hypertension is prescribed lisinopril. Which nursing monitoring parameter is most critical before
administering this medication?
, A. Serum glucose level
B. Blood pressure and potassium level
C. White blood cell count
D. Urine output
🟢 B. Blood pressure and potassium level
🔴 RATIONALE: ACE inhibitors like lisinopril lower blood pressure and can cause hyperkalemia by reducing
aldosterone secretion. Monitoring BP prevents administering to hypotensive patients, and checking potassium
identifies dangerous hyperkalemia.
Question 2
Which drug class is the preferred initial therapy for a patient with heart failure and reduced ejection fraction
(HFrEF)?
A. Calcium channel blockers
B. ACE inhibitors or ARBs
C. Beta-blockers only
D. Nitrates
🟢 B. ACE inhibitors or ARBs
🔴 RATIONALE: ACE inhibitors (or ARBs if ACE inhibitors are contraindicated) are first-line therapy for
HFrEF because they reduce afterload, prevent ventricular remodeling, and decrease mortality. Beta-blockers
are added subsequently.
